Mankind Pharma Limited (MANKIND) Share Analysis
NSE · Healthcare · Pharmaceuticals
Mankind Pharma Limited (NSE: MANKIND) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹2,301.00, market capitalisation ₹95,029 Cr, P/E 44.6, ROE 13.1%.
Get the AI verdict on MANKIND: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
MANKIND price and valuation
- Share price
- ₹2,301.00
- Market cap
- ₹95,029 Cr
- P/E ratio
- 44.6
- P/B ratio
- 5.83
- EPS
- ₹49.47
- Book value per share
- ₹395.00
- Dividend yield
- 0.04%
MANKIND profitability and growth
- ROE
- 13.1%
- ROCE
- 13.5%
- Debt to equity
- 0.38
- Revenue growth (3 yr)
- 18%
- Revenue growth (5 yr)
- 18%
- Profit growth (3 yr)
- 17%
- Profit growth (5 yr)
- 11%
MANKIND 52-week range
- 52-week high
- ₹2,674.00
- 52-week low
- ₹1,909.70
- Face value
- ₹1.00
MANKIND shareholding pattern
- Promoters
- 72.63%
- FIIs
- 9.45%
- DIIs
- 15.39%
- Public
- 2.53%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY Midcap 50, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.